Coherent Has Surged 400% in a Year but Our $201.63 Target Says Sell Now

24/7 Wall St. sets a $201.63 price target vs current price $253.22, implying -20.37% downside and a SELL recommendation with 90% confidence. Coherent reported Q2 FY26 revenue $1.685B (+17.5% YoY) and non-GAAP EPS $1.29 (beat), with Datacenter & Communications at $1.208B (72% of revenue, +34% YoY). The model flags a valuation disconnect (trailing P/E ~246x vs forward P/E 13x using forward EPS $5.00) and calls out risks including ~$3.5B long-term debt, $160.1M FY25 restructuring charges and recent net insider selling.

Analysis

Market pricing today is heavily binary: upside is concentrated in a successful, rapid roll‑out of next‑gen photonic integration while downside is driven by a single lumpy customer base and high leverage. That creates large option‑like returns but also makes quarter‑to‑quarter revenue cadence hostage to hyperscaler procurement waves rather than steady organic growth.

Beyond the headline product thesis, the real choke points are yield and test throughput in photonic packaging and thermal integration at scale; improvement there is a gating item that materially converts booked revenue into free cash flow. Firms that solve high‑volume photonics test, thermal interfaces, or automated assembly stand to capture margin pools and could see asymmetric upside if co‑packaged optics ramps faster than expected.

The most actionable catalysts to watch are (1) sequential booking quality and multi‑quarter, non‑lumpy purchase agreements from multiple hyperscalers, (2) gross margin recovery driven by packaging yields and lower unit test cost, and (3) capital structure flexibility as interest rates and covenant headroom matter when execution slips. These are 1–12 month observables; misses across two quarters increase the probability of forced deleveraging or equity dilution.

A disciplined playbook is warranted: position sizes should reflect a binary outcome and three‑to‑six month event windows. If management can demonstrate multi‑quarter, diversified hyperscaler commitments and sustained gross margin expansion, the market should re‑rate quickly; conversely, a single large customer pause or visible yield plateau will compress the multiple sharply and fast.

Key Decisions for Investors

• Initiate a tactical short of COHR equity (size 1–2% of portfolio, horizon 3–6 months). Set a hard stop at +12% and a take‑profit zone at roughly double the position’s risk (aim for 20–30% move). Rationale: high leverage to execution and hyperscaler cadence creates downside asymmetry over the next two earnings prints.
• Buy a defined‑risk bearish option spread on COHR: buy 6‑month ATM put and sell a lower strike put (ratio 1:1) to cap cost. Target payoff >2x premium if revenue cadence disappoints; limited capital at risk and preserves ability to re‑initiate larger short if earnings confirm weakness.
• Construct a contrarian, low‑cost bullish calendar structure: buy a 9–12 month COHR call spread funded by selling nearer‑term calls into the next two quarters. This captures convex upside if packaging yields or multi‑quarter hyperscaler contracts are announced while limiting carry if the near term is choppy.
• Pair trade to neutralize sector beta: short COHR and go long a diversified photonics components supplier (e.g., LITE) sized to 1:0.5 to reduce macro exposure, horizon 6–12 months. This isolates execution/market‑share risk in Coherent while taking a relative long on companies that win from a slower, more distributed optics ramp.